Skip to main content

Day: January 6, 2021

UniFirst Announces Financial Results for the First Quarter of Fiscal 2021

WILMINGTON, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company”) today reported results for its first quarter ended November 28, 2020 as compared to the corresponding period in the prior fiscal year:Q1 2021 Financial HighlightsConsolidated revenues for the first quarter decreased 4.0% to $446.9 million.Operating income was $56.0 million, a decrease of 6.7%.The quarterly tax rate increased to 25.0% compared to 22.1% in prior year.Net income decreased to $41.9 million, or 13.2%.Diluted earnings per share decreased to $2.20 from $2.52, or 12.7%.Steven Sintros, UniFirst President and Chief Executive Officer, said, “Overall, we are pleased with our first quarter results which were achieved despite the impact that the COVID-19 pandemic continues to have on our business and the economy as a whole.  ...

Continue reading

Volaris Group, through its AssetWorks Risk Management business, has acquired the assets of Oasys, LLC

PITTSBURGH, Jan. 06, 2021 (GLOBE NEWSWIRE) — Volaris Group Inc., through AssetWorks Risk Management Inc., has acquired the assets of Oasys, LLC, a custom software and solutions provider headquartered in Franklin, Wisconsin. Oasys helps improve the quality and effectiveness of education by providing an integrated suite of software products that give administrators, educators, and service providers the information they need to support special education students.“Oasys, LLC expands our offering for our current customers and enables us to offer a complete solution for K-12 school districts across the country,” said Michael Borello, Volaris Group Leader.Since 1999, Oasys has provided Special Education Software for K-12 school districts. With Oasys, school administrators and teachers can maintain the information needed for current, referred,...

Continue reading

Velatura Public Benefit Corporation Announces the Formation of Velatura HIE Corporation, Affiliation with Midwest Health Connection

GRAND RAPIDS, MICH., Jan. 06, 2021 (GLOBE NEWSWIRE) — Velatura Public Benefit Corporation (Velatura) today announced the formation of the Velatura HIE Corporation, a not-for-profit organization that will offer affiliation and integration opportunities to health information exchanges (HIEs) across the country. Missouri-based Midwest Health Connection (MHC), one of the largest HIEs in the United States, has joined as an inaugural member.On Dec. 31, 2020, MHC executed an affiliation agreement to become a subsidiary of the Velatura HIE Corporation and the first HIE to take advantage of the first-class services offered by Velatura. The new consolidated HIE service organization is one of the largest of its type in the country, connecting more than 1,300 healthcare organizations.Backed by more than 10 years of experience and a deep acumen...

Continue reading

Mersana Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that Anna Protopapas, President and Chief Executive Officer, will present a company overview at the 39th Annual J.P. Morgan Conference being held virtually on Wednesday, January 13, 2021 at 5:20 p.m. ET.   A live webcast of the presentation will be available on the Investors & Media section of Mersana’s website at www.mersana.com. An archived replay will be available for approximately 90-days following the presentation.About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical company using its differentiated and...

Continue reading

PowerFleet to Present at the 23rd Annual Needham Growth Conference on January 13, 2021

WOODCLIFF LAKE, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) — PowerFleet, Inc. (NASDAQ: PWFL), a global leader and provider of subscription-based wireless IoT and M2M solutions for securing, controlling, tracking, and managing high-value enterprise assets such as material handling equipment, tractor trailers, containers, cargo, automobiles, and light and heavy-duty truck fleets, has been invited to present at the 23rd Annual Needham Growth Conference, which is being held virtually on January 11-15, 2021.PowerFleet management is scheduled to present on Wednesday, January 13, 2021 at 9:15 a.m. Eastern time, with one-on-one meetings to be held the same day. The company’s presentation will be webcast live and available for replay here.For additional information or to schedule a one-on-one meeting with PowerFleet management, please contact...

Continue reading

AzurRx BioPharma to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference

DELRAY BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that the Company will be participating in the virtual H.C. Wainwright BioConnect 2021 Conference.James Sapirstein, President & CEO of AzurRx BioPharma, will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. Mr. Sapirstein will be available to provide an overview of the Company’s business and clinical development programs and discuss anticipated 2021 milestones.Details of the event are as follows:About AzurRx BioPharma, Inc.AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company specializing in the...

Continue reading

Midland States Bancorp, Inc. to Announce Fourth Quarter 2020 Financial Results on Thursday, January 28

EFFINGHAM, Ill., Jan. 06, 2021 (GLOBE NEWSWIRE) — Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its fourth quarter 2020 financial results after market close on Thursday, January 28, 2021.Midland States Bancorp will also host a conference call and webcast at 7:30 a.m. Central Time on Friday, January 29, 2021 to discuss its financial results. Analysts and investors may participate in the question-and-answer session.Conference Call, Replay and Webcast Information:Date: Friday, January 29, 2021Time: 7:30 a.m. Central TimeTelephone Access: (877) 516-3531; conference ID: 3179613Telephone Replay (available through February 5, 2021): (855) 859-2056; conference ID: 3179613Webcast Access: A live webcast will be available on the Webcasts and Presentations page in the Investor Relations section of the Company’s...

Continue reading

Power Control Reference Design Enables a Secondary Side Microcontroller to Control Primary Power

CHANDLER, Ariz., Jan. 06, 2021 (GLOBE NEWSWIRE) — In modern offline AC-DC power solutions, programmability and adaptive control offer the flexibility and intelligence needed by smart home devices to better interface with their power systems. In these systems, a secondary side microcontroller (MCU) is typically not capable of starting a system without the use of a separate bias power supply. A new reference design from Microchip Technology Inc. (Nasdaq: MCHP) solves this problem using the MCP1012 high voltage auxiliary AC-DC controller, demonstrating the ability to remove the independent bias power supply in many applications. The MCP1012 offline auxiliary device enables the system to transfer control of the power and duty cycle to a secondary MCU. The control between the system and the load can be more precise and purposefully coupled,...

Continue reading

Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update

Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Programs and Validated Technology PlatformsFirdapse® 2020 Net Revenues Estimate of approximately $118 Million; about 16% Increase From 2019Ended 2020 with Estimated $140 Million in Cash and InvestmentsCompany Highlights Current Product Development ProgramsCORAL GABLES, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced an expansion in its strategic priorities related to portfolio planning and research and development. Catalyst also provided preliminary net revenues and cash on hand for fiscal-year 2020,...

Continue reading

ARKO Announces Participation in the 2021 ICR Conference

RICHMOND, Va., Jan. 06, 2021 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“Arko” or the “Company”) today announced that the Company is scheduled to present at the 2021 ICR Conference on Monday, January 11, 2021, at 3:30 pm Eastern Time.The presentation will be webcast live over the internet and can be accessed at https://www.arkocorp.com/. A replay will be available for 30 days.About ARKO  Arko owns 100% of GPM Investments, LLC (“GPM”). Based in Richmond, VA, GPM was founded in 2003 with 169 stores and has grown through acquisitions to become the 7th largest convenience store chain in the United States, with approximately 2,950 locations comprised of approximately 1,350 company-operated stores and approximately 1,600 dealer sites to which it supplies fuel, in 33 states and Washington D.C. GPM operates in three segments: retail, which...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.